Precigen, Inc. (PGEN) stock
PGENNasdaqPharmaceutical PreparationsFiscal year ends December 31
$4.29−0.01 (-0.23%)
Close on Nov 17, 2026Market cap $1.54BP/E –Yield –
Precigen total debt
Total debt is short-term plus long-term borrowings on the balance sheet at the end of each period.
Precigen's total debt was $93.88M at Jun 30, 2026. For fiscal 2025 it was $93.17M. Over ten years it grew 27.0% a year on average. The highest annual figure on record is $217.99M in fiscal 2019.
Annual total debt
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | $93.17M | – |
| FY2024 | Dec 31, 2024 | $0 | – |
| FY2023 | Dec 31, 2023 | $0 | -100.0% |
| FY2022 | Dec 31, 2022 | $86.44M | -52.0% |
| FY2021 | Dec 31, 2021 | $179.93M | +4.7% |
| FY2020 | Dec 31, 2020 | $171.88M | -21.2% |
| FY2019 | Dec 31, 2019 | $217.99M | +3.0% |
| FY2018 | Dec 31, 2018 | $211.70M | +2534.0% |
| FY2017 | Dec 31, 2017 | $8.04M | +1.1% |
| FY2016 | Dec 31, 2016 | $7.95M | -6.8% |
| FY2015 | Dec 31, 2015 | $8.53M | -17.8% |
| FY2014 | Dec 31, 2014 | $10.37M | +527.3% |
| FY2013 | Dec 31, 2013 | $1.65M | – |
Quarterly total debt
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | $93.88M | – |
| Q1 FY2026 | Mar 31, 2026 | $93.52M | – |
| Q4 FY2025 | Dec 31, 2025 | $93.17M | – |
| Q4 FY2024 | Dec 31, 2024 | $0 | -100.0% |
| Q4 FY2023 | Dec 31, 2023 | $0 | -100.0% |
| Q3 FY2023 | Sep 30, 2023 | $0 | -100.0% |
| Q2 FY2023 | Jun 30, 2023 | $0 | -100.0% |
| Q1 FY2023 | Mar 31, 2023 | $13.82M | -93.1% |
| Q4 FY2022 | Dec 31, 2022 | $86.44M | -52.0% |
| Q3 FY2022 | Sep 30, 2022 | $82.07M | -54.4% |
| Q2 FY2022 | Jun 30, 2022 | $198.67M | +12.1% |
| Q1 FY2022 | Mar 31, 2022 | $201.47M | +15.4% |
| Q4 FY2021 | Dec 31, 2021 | $179.93M | +4.7% |
| Q3 FY2021 | Sep 30, 2021 | $180.17M | -7.2% |
| Q2 FY2021 | Jun 30, 2021 | $177.28M | -20.6% |
| Q1 FY2021 | Mar 31, 2021 | $174.52M | -20.9% |
| Q4 FY2020 | Dec 31, 2020 | $171.88M | -21.2% |
| Q3 FY2020 | Sep 30, 2020 | $194.22M | -9.9% |
| Q2 FY2020 | Jun 30, 2020 | $223.31M | +4.9% |
| Q1 FY2020 | Mar 31, 2020 | $220.62M | +2.8% |
| Q4 FY2019 | Dec 31, 2019 | $217.99M | +3.0% |
| Q3 FY2019 | Sep 30, 2019 | $215.47M | +17.3% |
| Q2 FY2019 | Jun 30, 2019 | $212.95M | +2643.5% |
| Q1 FY2019 | Mar 31, 2019 | $214.57M | +2607.2% |
| Q4 FY2018 | Dec 31, 2018 | $211.70M | +2534.0% |
| Q3 FY2018 | Sep 30, 2018 | $183.68M | +2164.3% |
| Q2 FY2018 | Jun 30, 2018 | $7.76M | -4.4% |
| Q1 FY2018 | Mar 31, 2018 | $7.93M | -0.9% |
| Q4 FY2017 | Dec 31, 2017 | $8.04M | +1.1% |
| Q3 FY2017 | Sep 30, 2017 | $8.11M | -3.7% |
| Q2 FY2017 | Jun 30, 2017 | $8.12M | – |
| Q1 FY2017 | Mar 31, 2017 | $8.00M | – |
| Q4 FY2016 | Dec 31, 2016 | $7.95M | – |
| Q3 FY2016 | Sep 30, 2016 | $8.42M | – |
See a number that looks wrong?